The two companies will undertake commercial activities using the Propeller clip-on sensor and software platform for use with GSK's ELLIPTA Inhaler.
Nothing has been decided yet, and we may still be far from seeing the new company emerging; both parties have been active in the digital health space.
GSK will use the sensor in the studies to automatically collect and record data on the inhaler's usage, and wirelessly transmit the data collected.
While GSK is looking to integrate Apple's platform into clinical trials, Purdue is only in the proof-of-concept stage in its ResearchKit exploration.
The two companies are exploring ways how mHealth and cloud-based technologies can impact patient engagement, data quality and operational efficiencies.